Upload
maude-cole
View
238
Download
0
Embed Size (px)
Citation preview
Urinary Tract Urolithiasis
Introduction
Found in Egyptian mummies. Stone surgeries earliest procedures described. Affects 1 - 5 % of the population. 10 – 20 % will require surgical intervention.
التصريف لمن عجز عن التأليف
(324-404 -936هـ / م1013 )
(Albucasis) الزهراوي
النساء لدى المثانة حصى إزالة عمليات أجرى من أولالمهبلية .بالجراحة
في الشرج إلى البول مجرى حول من أول كان كماالنساء في المهبل وإلى http://rowad.al-islam.com الرجال،
http://www.ummah.net/history/scholars/el_zahrawi/
Objectives• Epidemiology• To review the physical chemistry
of stone formation.• To develop a strategy for
diagnosis and management of a patient with a kidney stone.
• To rationalize a practical approach to stone prevention.
Epidemiology
• Annular incidence rate as high as 1%
• Lifetime risk– 10-20% in men– 5-10% in women.
• Most common type of stone is calcium oxalate containing stone (75%)
Epidemiology
• Recurrence rate – 15% in the 1st year .– 35% in 5 years .
• Common in white men > black.
• Occurs between 20-50 age group.
• M : F 3 : 1 in adult.
1989 Abdel Haleem
Chemical Composition of Stones
0
10
20
30
40
50
60
70
80
Calcium Struvite Uric Acid Cystine Others
%
Male : female = 3:1 Age 20-30 yearsMale : female = 5-2:1 Age 20-30 years
In SAX 2.5 in Saudis
Type and Causes of Stones
1. Calcium stones ( 75% ).
2. Infection stones (Struvite ) ( 15% ).
3. Uric acid stones (5 –10%)
4. Cystine stones ( 1% ).
1. Calcium stones ( 76% ).
2. Uric acid stones ( 20% ).
3. Infection stones ( Struvite ) ( 3-6% ).
4. Cystine stones ( 1% ).
In SA 1990 Abomelha
Stone Recurrence Rates
0
10
20
30
40
50
60
70
80
Italy Sweden Australia Alaska SA
%%
Pathogenesis of Stone Formation
Excessive Low inhibitory supersaturation activity
Randall’s Plaque
X100
What is this ?
Bilateral Staghorn Calculi
KUB
Infection stones
• Magnesium – ammonium – phosphate .• Triple phosphate stones .• Alkaline urine .• Urea – splitting bacteria .
• Proteus ***.
• Pseudomonas .
• Klebsiella .
• Staph
• ?? E. coli
?
Uric acid stone
• Product of purine metabolism .• Setting of stone formation :
• Low urine volumes .
• Acidic urine .
• High level of urinary uric acid .
• Radiolucent stone .
Symptoms of kidney stone
No symptoms
Renal colic
The Kidney Stone Scream
CLINICAL HISTORY Symptoms of a Kidney Stone
Sudden onset of severe pain
Starts in the back, radiates to the front & to groin
NauseatedBlood in urineIrritative voiding
CLINICAL HISTORYDetails
• Personal Hx:– Age at onset – Sex – Occupation – Geographic residence
• Fluid intake• Diet • PSHx:
• Interventional procedures, surgeries and • Stone episodes / Previous stone composition
• PMHx– Co-morbidities: PTH, Gout, bowel disease, Urinary tract
infections, renal disease
• Drug Hx: vitamins
• Family history
Physical exam
Appearance In pain Writhing or pacing Pale and sweating
VS Pulse, RR and BP elevated Temp normal
Abd exam Tender flank and costovertebral angle Ext genitalia and DRE (usually normal)
Work up of any Work up of any stone- forming stone- forming
patientpatient
Laboratory Studies
Blood CBC Creatinine Electrolytes
Urine Urinalysis +/- Culture Strain urine
Detailed: LAB EVALUATION SerumSerum• Calcium • Phosphorus • Uric acid • Creatinine • Alkaline phosphatase• PTHUrineUrine • Urinalysis • Culture • Fasting pH • 24-hr volume • Cyanide nitroprusside test
Urine chemistryUrine chemistry (24-hr volume with creatinine ) • Calcium • Phosphorus • Uric acid • Oxalate • Cystine • Citrate • Sodium • Magnesium Stone analysisStone analysis
Investigations of Stoneformers
StoneAnalysis for
composition
ImagingKUBIVPUSCT
• Ix– imaging
Calcium oxalate monohydrate (whewellite)—also called “mulberry stone
Uric acid calculus—
also called “jackstone
Staghorn calculus—magnesium ammonium phosphate (struvite).
Concentric character of magnesium ammonium phosphate struvite
Sites of Ureteric Stone Impaction
Ureteropelvic junction (UPJ)
Over the iliac vessels
Ureterovesical junction (UVJ)
5mm Calcification L3-4 Left
KUB
5mm Stone L3-4 Left
Ltretrogradepyelogram
No Stone Seen
KUB IVP
Delayed excretion at 3 min
3 minpost-injection
Mild Ureteric Dilatation at 10 min
10 minpost-injection
1.8 cm Proximal Left Ureter
Ultrasound
Stone Upper Right Ureter
CT Scan
Stone Upper Right Ureter
CT Scan
Triage Strategy
Inpatient Urology Consult
Poor pain controlInfectionSingle/both kidneys
blockedLarge stone Co-morbidities
Outpatient ConsultPush fluidsOral
analgesics/antiemeticsTamsulosin (Omnic)Strain urineReturn if increased pain
or feverFollow-up ± further
imaging
Management of Renal Colic
Intravenous fluids Adequate narcotic analgesia Adequate anti-emetics Strain urine Image to define diagnosis Triage to urology
– in/outpatient
• Acute management .• Diagnosis of the underlying pathology .
– 1st stone will have limited screening – Recurrent stone patient more extensive workup.
Urological ManagementActive surveillanceEndoscopic urologyPercutaneous urologyExtracorporeal
shockwave lithotripsy (ESWL)
Open urology/Lap
Right Ureteric Stent
Ureteroscopy and intracorporeal laser lithotripsy
Renal Access for Percutaneous Nephrolithotomy
Successful Lower Calyceal Access
Percutaneous Kidney Surgery
First Generation Lithotriptors
Contemporary ESWL Unit
Contemporary ESWL Unit
Goal of ESWL
Pre-op 1st Rx 2nd Rx
Open Stone Surgery
Nephrolithotomy
Pyelolithotomy
Ureterolithotomy
Cystolithotomy
Questions Regarding Investigations of SF
• Where?
• Why?
• Who?
• What?
• When?
Stone Management Team
Dietician
Imaging
Lab
Urologist
Patient
Management of urolithiasis
• Revolution.
• 15-30% of symptomatic stone will require surgeries.
• Stone < 7 mm to be given 4-8 weeks to pass on their own with alpha blocker and pain medication.
• Stone >10 mm unlikely to pass spontaneously .
Management of urolithiasis
• Indication for intervention :
•High grade urinary obstruction .•Infection •Uncontrolled pain •Impaired renal function
Management of urolithiasis
• Stone dissolution :
• Only uric acid and cystine stones .• If surgery needed it is needed .• Oral alkalinization for several weeks.• Direct irrigation of the stone with
alkaline solution is successful.• Failure to dissolve will require surgical
intervention .
Urinary Risk Factors
Calcium Oxalate
Low volume Hyperoxaluria Hypercalciuria
Fixed pH Hyperuricuria Low inhibitors
Calcium OxalateCalcium Oxalate
Manipulation of Urinary Risk Factors
Abnormality Dietary Rx Drug Rx
Low volume > Fluids > FluidsHyperoxaluria < Oxalate B6
> CalciumHypercalciuria < Sodium Citrate < Animal protein Thiazide
> Fibre Hyperuricosuria < Purine Allopurinol Fixed low pH < Animal protein Citrate
Bicarbonate
Fixed high pH NA NH 4Cl (?) Low inhibitors ? Citrate
Pentosan
Stone Prevention
>2.5 L urine per day
( pt with hypercalciuria).
except infective stone
(uric acid )
Summary Determine type of stone Measure urinary risk
factors Manipulate fluid/diet Arrange follow up Consider drugs
من وصايا الزهراوي المأثورةأوصيكم يا بني عن الوقوع فيما فيه الشبهة عليكم، فإنه قد يقع
إليكم في هذه الصناعة ضروب من الناس بضروب من ،األسقام
فمنهم من قد ضجر بمرضه وهان عليه الموت لشدة ما يجده من ،سقمه
.. ومنهم من قد يبذل ماله ويعينك به رجاء للصحة�باعدوا ألبتة بينكم وبين من هذه صفته ،فال ينبغي أن ُت
،وليكن ُتحذركم أشد من رغبتكم وحرصكم�قدموا على شيء من ذلك إال بعد علم يقين يصبح عندكم بما وال ُت
،ُتصير إليه العاقبة المحمودةواستعملوا في عالج مرضكم ُتقدمة المعرفة واإلنذار إلى ما ُتئول
،إليه السالمةفإن لكم في ذلك عونا على اكتساب الثناء، والمجد والذكر
.الكريم